SEC Comment Letter 0000000000-23-007999 to NOVAGANT CORP (NVGT) (CIK 0001089297)
NOVAGANT CORP (NVGT) (CIK 0001089297)
Date: July 26, 2023 · CIK: 0001089297 · Accession: 0000000000-23-007999
AI Filing Summary & Sentiment
File numbers found in text: 000-26675
Show Raw Text
United States securities and exchange commission logo
July 26, 2023
WeiQun Chen
Chief Financial Officer
Novagant Corp
Suite 2006, AIA Kowloon Tower, Landmark East
100 How Ming Street
KT, Hong Kong 999077
Re:Novagant Corp
Form 10-K for the Year Ended March 31, 2023
Filed June 29, 2023
File No. 000-26675
Dear WeiQun Chen:
We have limited our review of your filing to the submission and/or disclosures as
required by Item 9C of Form 10-K and have the following comments. In some of our comments,
we may ask you to provide us with information so we may better understand your disclosure.
Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond.
After reviewing your response to these comments, we may have additional comments.
Form 10-K for the Year Ended March 31, 2023
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections, page 42
1.We note that during your fiscal year 2022 you were identified by the Commission
pursuant to Section 104(i)(2)(A) of the Sarbanes-Oxley Act of 2002 (15 U.S.C.
7214(i)(2)(A)) as having retained, for the preparation of the audit report on your financial
statements included in the Form 10-K, a registered public accounting firm that has a
branch or office that is located in a foreign jurisdiction and that the Public Company
Accounting Oversight Board had determined it is unable to inspect or investigate
completely because of a position taken by an authority in the foreign jurisdiction. Please
provide the documentation required by Item 9C(a) of Form 10-K in the EDGAR
submission form “SPDSCL-HFCAA-GOV” or tell us why you are not required to do so.
Refer to the Staff Statement on the Holding Foreign Companies Accountable Act and the
Consolidated Appropriations Act, 2023, available on our website at
https://www.sec.gov/corpfin/announcement/statement-hfcaa-040623.
FirstName LastNameWeiQun Chen
Comapany NameNovagant Corp
July 26, 2023 Page 2
FirstName LastName
WeiQun Chen
Novagant Corp
July 26, 2023
Page 2
2.Please supplementally describe any additional materials that were reviewed and tell us
whether you relied upon any legal opinions or third party certifications such as affidavits
as the basis for your disclosure. In your response, please provide a similarly detailed
discussion of the materials reviewed and legal opinions or third party certifications relied
upon in connection with the required disclosures under paragraphs (b)(2) and (3).
3.We note your disclosure pursuant to paragraph b(4). Please clarify for us the difference
between your reference to official of the Chinese government rather than official of the
Chinese Communist Party. In order to clarify the scope of your review, please
supplementally describe the steps you have taken to confirm that none of the members of
your board or the boards of your consolidated foreign operating entities are officials of the
Chinese Communist Party. For instance, please tell us how the board members’ current or
prior memberships on, or affiliations with, committees of the Chinese Communist Party
factored into your determination. In addition, please tell us whether you have relied upon
third party certifications such as affidavits as the basis for your disclosure.
4.Please note that Item 9C requires that you provide disclosures for yourself and your
consolidated foreign operating entities, including variable interest entities or similar
structures.
•With respect to (b)(2), please supplementally clarify the jurisdictions in which your
consolidated foreign operating entities are organized or incorporated and provide the
percentage of your shares or the shares of your consolidated operating entities owned
by governmental entities in each foreign jurisdiction in which you have consolidated
operating entities in your supplemental response.
•With respect to (b)(3) and (b)(5), please provide the required information for you and
all of your consolidated foreign operating entities in your supplemental response.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Jimmy McNamara at 202-551-7349 or Andrew Mew at 202-551-3377
with any questions.
Sincerely,
Division of Corporation Finance
Disclosure Review Program